US FDA CBER Chief Calls For Industry-Academia Collaboration In Developing Treatments For Ultra-Rare Diseases

 
• By Joanne S. Eglovitch
Genetic Medicine with dna isolated on white.3d rendering
US FDA's Marks: Industry and academia could collaborate to treat the rarest of diseases

More from United States

More from North America